Locoregional recurrence patterns and prognostic outcomes in early-stage natural killer/T-cell lymphoma treated with sandwich chemoradiotherapy: A post hoc analysis of a randomized controlled trial.
Shu-Bei Wang, Jia-Yi Chen, Qi Song, Cheng Xu, Wei-Guo Cao, Yi-Min Han, Shu Cheng, Peng-Peng Xu, Hui-Juan Zhong, Wei-Li Zhao, Gang Cai
Pract Radiat Oncol S1879-8500(26)00203-1
摘要
摘要
BACKGROUND AND PURPOSE: This study aimed to evaluate the locoregional control in early-stage natural killer/T-cell lymphoma (NKTCL) patients treated with sandwich chemoradiotherapy. MATERIALS AND METHODS: We performed a post hoc analysis of 87 consecutive early-stage NKTCL patients enrolled in a prospective, multicenter, randomized phase III trial. All participants received standardized treatment comprising four cycles of asparaginase-based chemotherapy with integrated radiotherapy. RESULTS: With a median follow-up of 37.9 months, the 3-year survival outcomes of the cohort were: overall survival (OS) 87.1%, progression-free survival (PFS) 84.6%, and locoregional recurrence-free survival (LRRFS) 90.8%. Six patients experienced locoregional recurrence, with 4 in nasal cavity (4.6%), 4 in nasopharynx (4.6%), and 1 in cervical lymph node. Recurrence is typically in radiation field (5/6), often in the initial high-SUV region (4/6). Radiotherapy-chemotherapy interval (RCI) between 32-35 days was associated with improved prognosis, including OS (P = 0.043), PFS (P = 0.013), and LRRFS (P = 0.007) versus shorter RCI (21-31 days). Quantitative imaging analysis demonstrated that higher mean baseline apparent diffusion coefficient (ADC) values (≥0.1125 × 10⁻³mm²/s) was associated with an improved OS (95.2% vs 71.6%, P = 0.049). CONCLUSION: Asparaginase-based sandwich chemoradiotherapy shows favorable efficacy in early-stage NKTCL, with distinct locoregional recurrence patterns. RCI and ADC values emerge as critical prognostic factors, potentially informing treatment optimization.
KM 提取结果
0 个 Figure · 0 个 KM 面板